CD4+ lymphocytes from HIV-infected patients display impaired CD45-associated tyrosine phosphatase activity which is enhanced by anti-oxidants

Clinical and Experimental Immunology

Volumn 104, Issue 1, 1996, Pages 11-17

  Cayota, A ^a   Vuillier, F ^a   Gonzalez, G ^a   Dighiero, G ^a,b  

^a INSTITUT PASTEUR   (France)

^b U d'Immuno Hematologie d'I   (France)

Author keywords

CD45; CD4+ lymphocytes; HIV; oxidative stress; tyrosine phosphatase

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; BETA 2 MERCAPTOETHANOL; CD4 ANTIGEN; CD45 ANTIGEN; MERCAPTOETHANOL; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE;

EID: 0029991451     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-652.x     Document Type: Article

References (43)

1. Lane HC, Fauci A. Immunologic abnormalities in the acquired immunodeficiency syndrome. Ann Rev Immunol 1985; 3:477-500.
2. + cell numbers and clinical staging. J Clin Invest 1989; 84:1892-9.
3. Van Noesel CJM, Gruters RA, Terpstra FG, Schellekens PTA, Van Lier RAW, Miedema F. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus infected men. J Clin Invest 1990; 86:293-9.
4. Gruters RA, Terpstra FG, De Jong R, Van Noesel CJM, Van Lier RAW, Miedema FA. Selective loss of T cell functions in different stages of HIV infection. Eur J Immunol 1990; 20:1039-44.
5. Cayota A, Vuillier F, Scott-Algara D, Feuillie V, Dighiero G. Impaired proliferative capacity and abnormal cytokine profile of naive and memory CD4 T cells from HIV-seropositive patients. Clin Exp Immunol 1992; 88:478-83.
6. Pinching AJ, Nye KE. Defective signal transduction - a common pathway for cellular dysfunction in HIV infection. Immunol Today 1990; 7:256-9.
7. Gupta S, Vayuvegula B. Human immunodeficiency virus-associated changes in signal transduction. J Clin Invest 1987; 7:486-9.
8. lck together with impairment of T cell activation. J Immunol 1992; 149:285-94.
9. Linette GP, Hartzman RJ, Ledbetter JA, June CH. HIV-1-infected T cells show a selective signaling defect after perturbation of CD3/ antigen receptor. Science 1988; 241:573-6.
10. Kornfeld H, Cruikshank WW, Pyle SW, Berman JS, Center DM. Lymphocyte activation by HIV-1 envelope glycoprotein. Nature 1988; 335:445-8.
11. lck in CD4 T cells from HIV-1 infected patients. Int Immunol 1994; 6:611-21.
12. Trowbridge IS, Thomas ML. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Anu Rev Immunol 1994; 12:85-116.
13. Koretzky GA, Picus J, Schultz T, Weiss A. Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. Proc Natl Acad Sci USA 1991; 88:2037-41.
14. csk. Nature 1993; 365:156-9.
15. Tonks NK, Diltz CD, Fischer EH. Purification and assay of CD45: an integral membrane protein-tyrosine phosphatase. Methods Enzymol 1991; 201:442-51.
16. Baur A, Garber S, Peterlin M. Effects of CD45 on NK-kB. Implications for replication of HIV-1. J Immunol 1994; 152:976-81.
17. Hedley DW, Chow S. Evaluation of methods for measuring cellular glutathion content using flow cytometry. Cytometry 1994; 15:349-58.
18. Poot M, Kavanagh T, Kang HC, Haugland RP, Rabinovitch PS. Flow cytometry analysis of cell cycle dependent changes in cell thiol levels by combining a new laser dye with Hoechst 33342. Cytometry 1991; 12:184-7.
19. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148:2207-16.
20. Scott-Algara D, Lafon M, Vuillier F, Pialoux G, Dauguet C, Dighiero G. Viral superantigen-induced hyporesponsiveness of T cells and polyclonal B cell activation in HIV-1 infection. Eur J Immunol 1994; 24:2595-601.
21. Garcia-Morales P, Minami Y, Luong E, Klausner RD, Samelson LE. Tyrosine phosphorylation in T cells is regulated by phosphatase activity: studies with phenylarsine oxide. Proc Natl Acad Sci USA 1990; 87:9255-61.
22. Baruchel S, Wainberg MA. The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J Leuk Biol 1992; 52:111.
23. Dröge W, Eck H-P, Mihm S. HIV-induced cysteine deficiency and T-cell dysfunction - a rationale for treatment with N-acetylcysteine. Immunol Today 1992; 13:211-4.
24. Ameisen JC. Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer. AIDS 1994; 8:1197-213.
25. Gougeon M-L, Montagnier L. Apoptosis in AIDS. Science 1993; 260:1269-72.
26. + T cells from HIV-infected asymptomatic individuals. J Exp Med 1992; 175:331-40.
27. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994; 15:7-12.
28. Capon DJ, Ward RH. The CD4-gp120 interaction and AIDS pathogenesis. Ann Rev Immunol 1991; 9:649-78.
29. Cefai D, Debre P, Kaczorek M, Idziorek T, Autran B, Bismuth G. Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway. J Clin Invest 1990; 86:2117-24.
30. lck activation and TCR desensitization independent of TCR tyrosine phosphorylation. J Immunol 1994; 153:2905-17.
31. + T cell function by the HIV envelope protein, gp120. J Immunol 1988; 141:3715-7.
32. Hofmann B, Jakobsen KD, Odum N et al. HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via 2/phytohemagglutinin pathway. J Immunol 1989; 6:1874-80.
33. Weaver CT, Pingel JT, Nelson JO, Thomas ML. T-cell clones deficient in the expression of the CD45 protein tyrosine phosphatase have impaired responses to T-cell receptor stimuli. Mol Cell Biol 1991; 11:4415-22.
34. Koretzky GA, Picus J, Thomas ML, Weiss A. Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway. Nature 1990; 346:66-68.
35. Pingel JT, Thomas ML. Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation. Cell 1989; 58:1055.
36. Ostergaard HL, Schackelford DA, Hurley TR et al. Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines. Proc Natl Acad Sci USA 1989; 86:8959-63.
37. Cahir McFarland ED, Hurley TR, Pingel JT, Sefton BM, Shaw A, Thomas ML. Correlation between Src-family member regulation by the protein tyrosine phosphatase, CD45, and transmembrane signaling through the T-cell receptor. Proc Natl Acad Sci USA 1993; 90:1402-6.
38. lck upon CD45 triggering of Jurkat cells. Eur J Immunol 1994; 24:1255-61.
39. lck kinase creates a binding. Mol Cell Biol 1994; 14:1308-21.
40. Stover DR, Charbonneau H, Tonks NK, Walsh KA. Protein-tyrosine-phosphatase CD45 is phosphorylated transiently on tyrosine upon activation of Jurkat T cells. Proc Natl Acad Sci USA 1991; 88:7704-7.
41. Staal FJT, Roederer M, Israelski DM et al. Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals. AIDS Res Hum Retroviruses 1992; 8:305-10.
42. Olivier R, Lopez O, Mollereau M, Dragic T, Guetard D, Montagnier L. Prevention of early cell death in peripheral blood lymphocytes of HIV infected individuals by an anti-oxidant: N-acetyl-cysteine. In: Pasquier C, Olivier RY, Auclair C et al., eds. Oxidative stress, cell activation and viral infection. 1994:323.
43. Malorni W, Rivabene R, Teresa Santini M, Donelli G. N-acetylcysteine inhibits apoptosis and decreases viral particles in HIV-chronically infected U937 cells. FEBS 1993; 327:75-78.